Primary Malignant Tumours of the Body Of The Uterus

1975 ◽  
Vol 1 (12) ◽  
pp. 405-406
Author(s):  
G. R. Kurble ◽  
J. J. Campbell
Keyword(s):  
The Body ◽  
2021 ◽  
Author(s):  
Ji Zhou ◽  
Huijun Li ◽  
Cong Fang ◽  
Junye Tan ◽  
Peng Gao ◽  
...  

Abstract Objectives. Early detection of malignant tumour is a prerequisite for a successful treatment. Here we investigate if thymidine kinase 1 is more sensitive than imaging technology to discover small invisible malignant tumours.Material and Methods. The cellular concentration of TK1 was determined by a novel automatic chemiluminescence analyzer of magnetic particle immune sandwich minimum. The primary and secondary antibodies linked to the magnetic beads were chicken anti-human thymidine kinase 1 IgY-polyclonal antibodies (IgY pAb). The minimum number of cells able to be detected by the novel detection technology using an automatic chemiluminescence analyzer were determined based on the cellar TK1 concentration of low and high TK1 cell lines of known cell count.Results. The TK1 concentration of malignant cell was found to be 0.021 pg/cell. Assuming 200 pg of total protein/cell, TK1 corresponds to 0.01 % of the total protein/cell. The concentration of TK1 in human blood serum of malignant patients is in the range of 2-10 pmol/l (pM), corresponding to about 50 x106 growing cells in the body that release TK1 into 5 litre blood. The limit visibility by imaging of a tumour is about 1 mm in diameter, corresponding to about 109cells of a cell diameter of 1µm. Conclusion. TK1 is more sensitive than imaging.


2020 ◽  
Vol 24 (1) ◽  
pp. 53-56
Author(s):  
Ljiljana Vučković ◽  
Mirjana Miladinović ◽  
Vladimir Popović ◽  
Nevenka Lukovac Janjić ◽  
Milena Borilović ◽  
...  

SummaryBackground/Aim: Metastatic tumours make up only 1-3% of all malignant tumours of the oral region; however, in 25% of the total number of cases, they are the first sign of the disease. Usually, metastases in the oral region are followed by poor prognosis. Metastases are more common in the mandible than in the maxilla; in soft tissues, they most commonly occur in the attached gingiva and tongue. Malignant tumours of the lung, breast, kidney, liver, bone, prostate, thyroid gland, skin, colon and female genital organs most commonly give metastases in this region, usually in patients aged 40 to 70 years.Case Report: We present a patient aged 79 years with a tumour change in the body of the tongue. After histopathological and immunohistochemical analysis (Cytokeratin, Vimentin, CD 10 positive tumour cells, Cytokeratin 7, Cytokeratin 20 negative tumour cells), there was a suspicion of metastasis of clear cell renal carcinoma (CCRC). Due to renal cancer, the patient had left kidney operated seven years before the diagnosis of tongue tumour.Conclusions: Diagnosis of metastatic tumours of the oral region is a great challenge, both for clinicians and for histopathologists. Since it is a heterogeneous group of neoplasms, standard histopathological tissue processing, is not always sufficient to determine the histological type of tumour and its primary origin. In the analysis of metastatic tumours of the oral region, team work is important and careful clinical and histopathological assessment lead to definitive and accurate diagnosis.


2018 ◽  
Vol 2 (1) ◽  

Cell division is a normal process in multicellular organisms. Growth and repair (replacement of dead cells) take place as a result of cell division (mitosis). Except for cells like the liver and brain cells, which rarely divide in the mature adult, most cells undergo frequent division. Sometimes, however, cell division becomes very rapid and uncontrolled, leading lo cancer. It should be clearly understood that rapid growth means a high rate of cell division for a particular cell type. It is possible for perfectly normal cells, e. g. the blood-forming cells, to have a higher rate of division than some cancerous cells. Cells which undergo rapid, abnormal and uncontrolled growth at the cost of remaining ceils are called neoplastic cells. The growths resulting from the division of such cells are called neoplastic growths or tumours. Tumours are commonly classified as benign and malignant. Abnormal and persistent cell division that remains localized at the spot of origin results in the so-called benign tumours. It should be noted, however, that benign tumours can sometimes be fatal, e’ g, brain tumours that cause pressure on vital centres. Benign tumours usually contain well-differentiated cells. Tumour cells may be carried by the blood stream, or the lymphatic system, or by direct penetration to other parts of the body, where they may induce secondary (metastatic) tumours. Such invasive cancers ultimately result in the death of the organism and are therefore said to be malignant. Malignant tumours usually contain undifferentiated cells, often with large nuclei and nucleoli.


Author(s):  
Rajani Singh

Cerebellum is the largest part of the hindbrain and weighs about 150 g. It is enshrined in posterior cranial fossa behind the pons and medulla oblongata and separated from these structures by cavity of fourth ventricle. It is connected to brainstem by three fibre tracts known as cerebellar peduncles. Cerebellum controls the same side of body. It precisely coordinates skilled voluntary movements by controlling strength, duration and force of contraction, so that they are smooth, balanced and accurate. It is also responsible for maintaining equilibrium, muscle tone and posture of the body. This is achieved through the use of somatic sensory information in modulating the motor output from the cerebrum and brainstem. Sherrington regarded cerebellum as the head ganglion of the proprioceptive system. Dysfunction of cerebellum along with degenerative diseases of cerebellum such as spinocerebellar ataxia, multiple sclerosis, malignant tumours, etc. may culminate into disequilibrium, hypotonia, difficulty in talking, sleeping, maintaining muscular coordination and dyssynergia which at times may be life threatening. Hence, knowledge of anatomy of cerebellum is imperative for neuroanatomists and neurosurgeons.


2017 ◽  
Vol 5 ◽  
pp. 2050313X1772406
Author(s):  
Reubina Wadee

Background: Leiomyosarcomas of soft tissue are malignant tumours that are not infrequently encountered in clinical medicine and histopathology. Such sarcomas of the eye are, however, a rare occurrence. Purpose: Herein, the histopathological features of a case of conjunctival leiomyosarcoma are described. A 38-year-old HIV-positive male, who was otherwise fit and healthy, presented with redness of his right eye and a mass of the conjunctiva. Clinically, he did not have any soft-tissue masses elsewhere in the body. Method: He underwent monoblock excision of the conjunctival mass which was confirmed histologically to be a leiomyosarcoma. Unfortunately, the patient had not returned for follow-up examination. Conclusion: The differential diagnosis of a conjunctival spindle cell neoplasm is broad. While a spindle cell carcinoma is the most likely tumour, other tumours must be borne in mind so as not to misdiagnose primary sarcomas in this unusual location.


Dr. J. A. Murray, F. R. S.: The investigations of the last 30 years have proved that the cells of the higher vertebrates, under appropriate conditions, are capable of unlimited proliferation, and it is of importance in discussing the problems of experimental carcinogenesis to remember this fact, and to have clear ideas of the characteristic features of the proliferation of new growths, including cancer. This is very necessary because nothing is commoner in the literature of the subject than loose statements that this or that agent confers on the cells powers of unlimited proliferation, which is nonsense, seeing they already possess these powers. The essential feature is the uncontrolled or autonomous character of the cellular proliferation, that is to say, the agencies which are effective in the body in limiting the rate and amount of growth and cell division are ineffective against true new growths. This is true of both classes of new growths, the benign as well as the malignant. Examples are seen in the fatty tumours, lipomata, which go on increasing in size in an emaciated individual and the uterine myomata which grow progressively even after the menopause while the ordinary uterine muscle is shrinking or quiescent. The malignant new growths, carcinoma and sarcoma, exhibit this feature still more clearly because many show a more rapid rate of growth. The other distinctive features of the malignant as contrasted with the benign new growths are differences in degree, rather than in kind, and their more perfect independence or autonomy, manifests itself in infiltrative progress, disorganizing and destroying the normal tissues encountered, by pressure from without, or occlusion and rupture of blood supply. The stretching and tearing of the walls of blood and lymph vessels opens the way for the entrance of smaller or larger aggregates of the parenchyma cells into the vessels and these, transferred to remote situations further exhibit their independence and adaptability to new surroundings, by the formation of secondary centres of growth, or metastases. It is these manifestations of neoplasia which render cancer so formidable a problem in treatment. These new proliferative conditions arise in limited localized foci and once they have reached a size sufficient for recognition further increase takes place only from the descendants of the already transformed cells without fresh accessions from the surrounding elements of the same kind. The original focus may be solitary, or several foci (all minute) may appear almost simultaneously, and soon fuse into one tumour. One type of cell only acquires these new properties and by its multiplication gives rise to the new formation, so that it is usually possible by microscopic examination to their the tissue of origin, even after the tumour has reached a great size. The growths of any one tissue do not reproduce the full characters of the differentiated tissue of origin to the same extent. They form a continuous series ranging from apparently perfect reproduction of the histology of the parent tissue to a condition in which no specific differentiation can be recognized at all. Much unnecessary ink has been split in devising suitable words to describe this "undifferentiated," "dedifferentiated," "anaplastic" or "embryonic" state, but what is worth emphasizing is the fact the degree to which it occurs is relatively fixed in any one new growth, and is maintained practically unaltered throughout its course. The rate of growth shows a similar uncorrelated series of gradations and there is much evidence to show that this also is (or at least may be), an initial, inherent, quality of the essential constituent parenchyma cells.


1935 ◽  
Vol 31 (8-9) ◽  
pp. 1097-1104
Author(s):  
M. S. Znamensky

In 1915, Prof. Dеlbеt, who was not satisfied with the method of pure asepsis in the treatment of wounds because of its passivity, tried to find a remedy that would actively help the body to fight the infection. In his search, he came across magnesium halide salts (Mg) that met his requirements. But in the process of working with magnesium salts, mainly magnesium chloride, some of their properties were discovered, which attracted Dеlbеt to another, no less interesting area, namely malignant tumours.


2019 ◽  
Author(s):  
Maximilian A. R. Strobl ◽  
Andrew L. Krause ◽  
Mehdi Damaghi ◽  
Robert Gillies ◽  
Alexander R. A. Anderson ◽  
...  

AbstractInvasion of healthy tissue is a defining feature of malignant tumours. Traditionally, invasion is thought to be driven by cells that have acquired all the necessary traits to overcome the range of biological and physical defences employed by the body. However, in light of the ever-increasing evidence for geno- and phenotypic intra-tumour heterogeneity an alternative hypothesis presents itself: Could invasion be driven by a collection of cells with distinct traits that together facilitate the invasion process? In this paper, we use a mathematical model to assess the feasibility of this hypothesis in the context of acid-mediated invasion. We assume tumour expansion is obstructed by stroma which inhibits growth, and extra-cellular matrix (ECM) which blocks cancer cell movement. Further, we assume that there are two types of cancer cells: i) a glycolytic phenotype which produces acid that kills stromal cells, and ii) a matrix-degrading phenotype that locally remodels the ECM. We extend the Gatenby-Gawlinski reaction-diffusion model to derive a system of five coupled reaction-diffusion equations to describe the resulting invasion process. We characterise the spatially homogeneous steady states and carry out a simulation study in one spatial dimension to determine how the tumour develops as we vary the strength of competition between the two phenotypes. We find that overall tumour growth is most extensive when both cell types can stably coexist, since this allows the cells to locally mix and benefit most from the combination of traits. In contrast, when inter-species competition exceeds intra-species competition the populations spatially separate and invasion arrests either: i) rapidly (matrix-degraders dominate), or ii) slowly (acid-producers dominate). Overall, our work demonstrates that the spatial and ecological relationship between a heterogeneous population of tumour cells is a key factor in determining their ability to cooperate. Specifically, we predict that tumours in which different phenotypes coexist stably are more invasive than tumours in which phenotypes are spatially separated.


2010 ◽  
Vol 138 (3-4) ◽  
pp. 244-247 ◽  
Author(s):  
Radoje Colovic ◽  
Slavko Matic ◽  
Marjan Micev ◽  
Nikica Grubor ◽  
Stojan Latincic

Introduction. Glucagonomas are rare, frequently malignant tumours, arising from the Langerhans' islets of the pancreas. They usually secrete large amounts of glucagon that can cause a characteristic 'glucagonoma syndrome', which includes necrolytic migratory erythema, glucose intolerance or diabetes, weight loss and sometimes, normochromic normocytic anaemia, stomatitis or cheilitis, diarrhoea or other digestive symptoms, thoromboembolism, hepatosplenomegaly, depression or other psychiatric and paraneoplastic symptoms. In certain cases, some or all glucagonoma symptoms may appear late, or even may be completely absent. Case Outline. The authors present a 43-year-old woman in whom an investigation for abdominal pain revealed a tumour of the body of the pancreas. During operation, the tumour of the body of the pancreas extending to the mesentery measuring 85?55?55 mm was excised. Histology and immunohistochemistry showed malignant glucagonoma, with co-expression of somatostatin in about 5% and pancreatic polypeptide in a few tumour cells. The recovery was uneventful. The patient stayed symptom-free with no signs of local recurrence or distant diseases 15 years after surgery. Conclusion. Glucagonoma syndrome may be absent in glucagonoma tumour patients so that in unclear pancreatic tumours the clinician should frequently request the serum hormone level (including glucagon) measurement by radioimmunoassay and the pathologist should perform immunohistochemistry investigation. Those two would probably result in discovery of more glucagonomas and other neuroendocrine tumours without characteristic clinical syndromes.


Sign in / Sign up

Export Citation Format

Share Document